Company Profile

CellMosaic is a private biotech company focusing on the development of bioconjugation reagents and platform technologies for drug development, biodetection, and basic research. CellMosaic has been developing new crosslinking chemistries, a small molecule and biologic drug conjugation/delivery platform, and single or site-specific labeling methods for biopolymers. They recently filed a patent application for new crosslinking reagents and developed our proprietary AqueaTether™ (AqT™) technology platform for drug bioconjugation and delivery. Additionally, they offer bioconjugate drug development through either the classical approach or their proprietary AqT™ technologies. CellMosaic can also facilitates biological research by offering a wide range of crosslinking reagents, ready-to-go kits, bioconjugates, and custom bioconjugation.